Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
Published on: April 26, 2024
Engineering a yeast double-molecule carrier for drug screening
Qiyun Zhang1,2,3, Sheng Hu4, Ke Wang5,6
1a Laboratory of Drug Discovery and Molecular Engineering, Department of Medicinal Plants, College of Plant Science and Technology , Huazhong Agricultural University (HZAU) , Wuhan , China.
Researchers developed a novel yeast-based platform for rapid, high-throughput screening of anti-inflammatory drugs. This method quantifies cellular inflammation by measuring yeast-mammalian cell binding, identifying potential drug candidates efficiently.
Area of Science:
- Biochemistry
- Cell Biology
- Drug Discovery
Background:
- Yeast is a valuable tool in biochemical and genetic studies due to its simple structure and ease of manipulation.
- Developing efficient screening platforms is crucial for discovering drugs targeting inflammation and related diseases.
Purpose of the Study:
- To engineer a yeast-based double-molecule carrier system for a high-throughput anti-inflammatory drug screening platform.
- To establish an "inflammatory index" for quantifying chemical effects on cellular inflammation.
Main Methods:
- Engineered yeast to display the I domain of lymphocyte function-associated antigen 1 on its surface, targeting intercellular adhesion molecule 1 on mammalian cells.
- Expressed green fluorescent protein (GFP) intracellularly in yeast for quantifiable measurement of yeast-mammalian cell binding via GFP intensity.
- Screened 1340 chemicals to determine their inflammatory potency.
Main Results:
- Successfully developed a yeast platform that quantifies cellular inflammation through GFP intensity, reflecting yeast-mammalian cell binding.
- Identified and verified 1 inflammation-inducing and 1 inflammation-reducing compound in vitro and in vivo.
- Demonstrated the platform's ability to provide a swift, facile, and high-throughput method for drug discovery.
Conclusions:
- The engineered yeast system serves as an effective protein-level screening platform for anti-inflammatory drug discovery.
- This approach offers a simplified, high-throughput alternative to sophisticated instruments for identifying inflammation modulators.
- The developed method facilitates drug discovery for inflammatory diseases by providing a robust screening tool.
Related Concept Videos
Electron Carriers
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
Yeast Signaling
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Carrier Transport
Drift Current:
The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by:
The ADP/ATP Carrier Protein
Carrier Generation and Recombination
This process is given by the generation rate G and is efficient due to the conservation of momentum between the valence band maximum and conduction band minimum.
Indirect generation involves an...

